We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
How the EMERGE guideline on medication adherence can improve the quality of clinical trials.
- Authors
Eliasson, Lina; Clifford, Sarah; Mulick, Amy; Jackson, Christina; Vrijens, Bernard
- Abstract
Medication adherence in drug trials is suboptimal, affecting the quality of these studies and adding significant costs. Nonadherence in this setting can lead to null findings, unduly large sample sizes and the need for dose modification after a drug has been approved. Despite these drawbacks, adherence behaviours are not consistently measured, analysed or reported appropriately in trial settings. The ESPACOMP Medication Adherence Reporting Guideline (EMERGE) offers a solution by facilitating a sound protocol design that takes this crucial factor into account. This article summarises key evidence on traditional and newer measurements of adherence, discusses implementation in clinical trial settings and makes recommendations about the analysis and interpretation of adherence data. Given the potential benefits of this approach, the authors call on regulators and the pharmaceutical industry to endorse the EMERGE guideline.
- Subjects
PATIENT compliance; CLINICAL trials; NOCEBOS; CLINICAL drug trials; SOUND design; GUIDELINES
- Publication
British Journal of Clinical Pharmacology, 2020, Vol 86, Issue 4, p687
- ISSN
0306-5251
- Publication type
Article
- DOI
10.1111/bcp.14240